+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Avibactam"

Antibiotic Resistance Global Market Report 2024 - Product Thumbnail Image

Antibiotic Resistance Global Market Report 2024

  • Report
  • February 2024
  • 175 Pages
  • Global
From
Antibiotics Global Market Report 2024 - Product Thumbnail Image

Antibiotics Global Market Report 2024

  • Report
  • February 2024
  • 175 Pages
  • Global
From
  • 3 Results (Page 1 of 1)
Loading Indicator

Avibactam is a non-β-lactam β-lactamase inhibitor used in combination with antibiotics to treat infections caused by bacteria. It is used in combination with antibiotics to treat infections caused by bacteria that produce certain types of β-lactamases, enzymes that can inactivate certain antibiotics. Avibactam works by blocking the action of these enzymes, allowing the antibiotic to work more effectively. Avibactam is used in combination with antibiotics to treat a variety of infections, including urinary tract infections, skin and soft tissue infections, and pneumonia. Avibactam is a relatively new class of antibiotics, and is currently used in combination with other antibiotics to treat a variety of infections. It is an important tool in the fight against antibiotic resistance, as it helps to prevent bacteria from becoming resistant to antibiotics. Some companies in the Avibactam market include AstraZeneca, Merck, Pfizer, and Allergan. Show Less Read more